Items Tagged with 'GLP-1 medicines'

As weight-loss drugs like Ozempic and Wegovy become more accessible, U.S. food industries are scrambling to understand how the drugs could reshape consumer demand.

In this opinion piece, Wendelyn Jones, executive director of the Institute for the Advancement of Food and Nutrition Sciences, highlights GLP-1 medications and their impact on obesity and food innovation.